Cargando…

The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the most common malignant tumor of the head and neck. HNSCC mainly affects the oral cavity and the laryngeal, laryngopharyngeal, and oropharyngeal tracts. The high incidence, hidden onset, low survival rate, and unsatisfactory effects of treatment eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Dong, Deng, Yongqin, Shen, Zhisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275198/ https://www.ncbi.nlm.nih.gov/pubmed/34267526 http://dx.doi.org/10.2147/OTT.S317234

Ejemplares similares

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

The Role and Mechanism of Long Non-Coding RNA HOTAIR in the Oncogenesis, Diagnosis, and Treatment of Head and Neck Squamous Cell Carcinoma
por: Xiang, Yuandi, et al.
Publicado: (2023)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

The expression profile and clinical application value of hsa_circ_0016148 in head and neck squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2021)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
por: Gu, Shanshan, et al.
Publicado: (2023)

Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
por: Shen, Zhisen, et al.
Publicado: (2014)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”
por: Cao, Wei, et al.
Publicado: (2021)

Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction
por: Li, Qun, et al.
Publicado: (2021)

The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma
por: Jiang, Man, et al.
Publicado: (2021)

T cell effects and mechanisms in immunotherapy of head and neck tumors
por: Xiang, Yizhen, et al.
Publicado: (2023)

Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma
por: Tang, Yun, et al.
Publicado: (2021)

Integrative network analysis reveals subtype-specific long non-coding RNA regulatory mechanisms in head and neck squamous cell carcinoma
por: Li, Jiang, et al.
Publicado: (2022)

The non-coding landscape of head and neck squamous cell carcinoma
por: Zou, Angela E., et al.
Publicado: (2016)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Circulating small non coding RNA signature in head and neck squamous cell carcinoma
por: Martinez, Berta Victoria, et al.
Publicado: (2015)

A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma
por: Zhang, Chengyao, et al.
Publicado: (2020)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis‐related long non‐coding RNA signature
por: Huang, Qi, et al.
Publicado: (2022)

The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma
por: Cao, Yujie, et al.
Publicado: (2022)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

Spatial metabolomics in head and neck tumors: a review
por: Zheng, Ye, et al.
Publicado: (2023)

MALAT1 Long Non-Coding RNA: Functional Implications
por: Arun, Gayatri, et al.
Publicado: (2020)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Identification and validation of potential long non-coding RNA biomarkers in predicting survival of patients with head and neck squamous cell carcinoma
por: Li, Junyu, et al.
Publicado: (2019)

Ferroptosis-Related Long Non-Coding RNA Signature Contributes to the Prediction of Prognosis Outcomes in Head and Neck Squamous Cell Carcinomas
por: Jiang, Wenru, et al.
Publicado: (2021)

LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Establishment and validation of a redox-related long non-coding RNAs prognostic signature in head and neck squamous cell carcinoma
por: Liu, Kaitai, et al.
Publicado: (2022)

Correction: LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2
por: Duan, Yuansheng, et al.
Publicado: (2023)

Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins
por: Fang, Zhengyu, et al.
Publicado: (2016)

Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method
por: Huang, Teng, et al.
Publicado: (2018)

Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Zhou, Xuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5r5dvc42b8banni2jf8khs1fok